**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 4202-38-4 |Dodecane, 1-isocyanato- | 99 | 224-111-0 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.Moisture
sensitive.Lachrymator (substance which increases the flow of tears).
Potential Health Effects
Eye:
Causes eye irritation. Lachrymator (substance which increases the
flow of tears). May cause chemical conjunctivitis.
Skin:
Causes skin irritation. Organic isocyanates can cause local
irritation and allergic reactions.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. The toxicological properties of this substance have not
been fully investigated.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of
this substance have not been fully investigated. At high
concentrations, isocyanates affect mucous membranes of the
respiratory tract and may lead to fatal pulmonary edema. Exposure to
low and often even unmeasurable isocyanate concentration results in
sensitization. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed. Chronic overexposure to isocyanates has been
reported to cause lung damage, including decreased lung fuction,
which may be permanent.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid. Do
NOT allow victim to rub eyes or keep eyes closed.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Vapors may be heavier
than air. They can spread along the ground and collect in low or
confined areas. Containers may explode when heated.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Do NOT get water
inside containers. Cool containers with flooding quantities of water
until well after fire is out. Use water spray, dry chemical, carbon
dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Remove all
sources of ignition. Provide ventilation. Do not get water inside
containers.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid
contact with eyes, skin, and clothing. Keep container tightly closed.
Avoid ingestion and inhalation. Use with adequate ventilation. Do not
allow contact with water. Wash clothing before reuse. Keep from
contact with moist air and steam.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from moisture.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 4202-38-4:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 132 deg C @ 5.00MM HG
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 134 deg C ( 273.20 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: negligible in water
Specific Gravity/Density: .877
Molecular Formula: C13H25NO
Molecular Weight: 211.35
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, ignition sources, moisture, excess heat.
Incompatibilities with Other Materials:
Moisture, alcohols, water, strong bases, strong oxidizing agents,
acids, amines.
Hazardous Decomposition Products:
Hydrogen cyanide, carbon monoxide, oxides of nitrogen, irritating and
toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 4202-38-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Dodecane, 1-isocyanato- -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: ISOCYANATES, TOXIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2206
Packing Group: III
IMO
Shipping Name: ISOCYANATES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 2206
Packing Group: III
RID/ADR
Shipping Name: ISOCYANATES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 2206
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 37/39 Wear suitable gloves and eye/face
protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 4202-38-4: No information available.
Canada
CAS# 4202-38-4 is listed on Canada's NDSL List.
CAS# 4202-38-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 4202-38-4 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 7/06/1999 Revision #3 Date: 8/22/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-Methylalanine, 97% (titr.)
| 62-57-7 |
|
2,2'-Biquinoline, 98%
| 119-91-5 |
|
Zinc cyclohexanebutyrate dihydrate
| 38582-18-2 |
|
d-(+)-Mannose, 99+%
| 3458-28-4 |
|
N-Benzylidenemethylamine, 99%
| 622-29-7 |
|
p-Nitrophenol
| 100-02-7 |
|
3-Endo-Aminobicyclo??2.2.1??Heptane-2-Endo-Carboxylic Acid Monohydrate,
| 104308-53-4 |
|
2-Naphthyl-beta-D-galactopyranoside
| 33993-25-8 |
|
Triethylborane, 1M solution in THF
| 97-94-9 |
|
cis-4-Methyl-2-pentene, 99%
| 691-38-3 |
|
4-Bromoisophthalic Acid, 97%
| 6939-93-1 |
|
9,10-Dihydroanthracene, techn. 90%
| 613-31-0 |
|
Dodecyl isocyanate, 99%
| 4202-38-4 |
|
Nickel on Silica/Alumina, Catalyst, 64% Ni Reduced and Stabilized
| |
|
Trans-(-)-1,4-Di-O-Tosyl-2,3-0-Isopropylidene-L-Threitol, 97%
| 37002-45-2 |
|
Ethyl(ethoxymethylene)cyanoacetate, 98%
| 94-05-3 |
|
Nicotinamide Adenine Dinucleotide Trihydrate, 98% (UV-Vis)
| 53-84-9 |
|
DL-Methionine, 99%
| 59-51-8 |
|
3',4'-(Didecyloxy)benzaldehyde, 96%
| 118468-34-1 |
|
p-Xylene
| 106-42-3 |
|
3,4-Difluoroanisole, 98+%
| 115144-40-6 |
|
1-Phenylethyl propionate, 98+%
| 120-45-6 |
|
Palladium (II) Chloride
| 7647-10-1 |
|
1-Methyl-2-benzimidazolinone, 98%
| 1849-01-0 |
|
Pancreatin
| 8049-47-6 |
|
Paraformaldehyde
| 30525-89-4 |
|
Biphenyldimethylsilyl Chloride, 99%
| 0-00-1 |
|
1-Pentadecanol, 99+%
| 629-76-5 |
|
4-(Ethoxyfluorophosphinyloxy)-Tempo, Free Radical
| 37566-53-3 |
|
Sulfuric Acid-D2, 97% +/- 1% Solution in D2O, 99.5+ Atom % D
| 7789-20-0 |
|
trans-3-Hexene, 99+%
| 13269-52-8 |
|
1,1-Diethoxy-2-Cyanoethane, 95%
| 2032-34-0 |
|
Dl-Octopamine Hydrochloride, 98%
| 770-05-8 |
|
2,5-Dihydroxyphenylacetic Acid Gamma-Lactone, 97%
| 2688-48-4 |
|
4-Propoxyphenol, 96%
| 18979-50-5 |
|
(-)-Carvyl Acetate, Mixture of Isomers, 98+%
| 97-42-7 |
|
4-Bromobenzenesulfonyl Chloride, 98%
| 98-58-8 |
|
Sodium Hyaluronate, 85%
| 9067-32-7 |
|
5-Hydroxyisoquinoline, tech., 90%
| 2439-04-5 |
|
Poly(4-Chlorostyrene)
| 24991-47-7 |
|
(r)-(-)-2-Phenylpropionic acid, 99%
| 7782-26-5 |
|
Nitro-L-Arginine, 99+%(E.E.)
| 2149-70-4 |
|
Dl-serine, 99%
| 302-84-1 |
|
N, N-Bis-(2,2-=Diethoxyethyl)-Methylamine, 97%
| 6948-86-3 |
|
Eriochrome Blue Black B
| 3564-14-5 |
|
D-Alanine, 99+%
| 338-69-2 |
|
Pinene (Pract)
| 80-56-8 |
|
2-Acetylcyclopentanone, 99%
| 1670-46-8 |
|
1-Benzyl-3-Carbethoxy-4-Piperidone Hydrochloride 97% (TLC)
| 1454-53-1 |
|
1,2-Propanediamine, 97% (titr.)
| 78-90-0 |
|
|